However, after 6 weeks of exosomes tail vein injection, the symptoms of obesity, hyperglycemia, and liver enlargement and pallor in HFD-fed mice were alleviated, and the levels of ALT and AST, indicators of liver damage, were significantly reduced. The gene discussed is GPT; the disease is Hyperglycemia.